Want to join the conversation?
$ACET said that its subsidiary, Rising Pharmaceuticals, is launching an FDA-approved generic version of $GSK's Avodart (Dutasteride) Softgel Capsules 0.5 mg in the U.S. market. According to IMS Health, U.S. market for Dutasteride, which is used for the treatment of symptomatic BPH in men with enlarged prostate, is about $452MM.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.